1News Report – Medsafe Approves 10 Minute Ocrevus Injection
Watch Graham Walker, person with MS, President of MS Taranaki and Co-Vice President of MSNZ discuss the life-changing news that Medsafe has approved the 10 minute Ocrevus injection, accompanied with comments from Amanda Rose, MSNZ National Manager on 1News, 29th April 2025. Watch here: https://www.youtube.com/watch?v=1YQitPAsR5A We encourage those with lived experience to provide their stories […]
Medsafe Approves 10 Minute Ocrevus Injection; TVNZ Breakfast Interview with Graham Walker
Watch Graham Walker, President of MS Taranaki and Co Vice-President of MSNZ, discuss the newly approved 10 minute Ocrevus injection with Jenny-May on TVNZ’s Breakfast show. Click here: https://youtu.be/powx9Ukm3Dw We encourage those with lived experience to provide their stories to us of barriers they experience accessing treatment. These will help to strengthen our message to Pharmac around […]
Ocrelizumab Subcut Receives Medsafe Registration as Pressure Mounts to Fund Wider Range of MS Treatment Options
Photo by Kristine Wook, Unsplash. Medsafe have approved the registration of Ocrevus ® Subcutaneous (SC) (ocrelizumab and hyaluronidase) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The announcement on 24th April is welcomed by Multiple Sclerosis New Zealand. “The registration of Ocrevus SC is […]
Ocrevus for PPMS – Your Questions Answered
Here’s what you need to know about Ocrevus (ocrelizumab) for Primary Progressive MS. Download PDF copy here: PPMS Ocrevus FAQ – 13 September 2023. What medicines are available to treat Primary Progressive Multiple Sclerosis (PPMS)? There is only one medicine, Ocrevus® (ocrelizumab), that has been approved by Medsafe to treat primary progressive MS […]